Moolec Science SA
MLECHealthcareNASDAQBiotechnology · Last scanned Oct 24, 2026
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Moolec Science SA focuses on Biotechnology services and products. Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and. The $1.2M market capitalization puts MLEC squarely in micro-cap range for its industry. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas.
Market Cap
$1.2M
Beta
—
P/E (TTM)
—
P/E (Fwd)
-7.17
EPS (TTM)
$-203.56
EPS (Fwd)
$-0.24
ROE
—
ROA
—
Cash
—
Total Debt
—
Free CF
—
52W Change
-83.1%
Annual Financials
Cash vs Debt
Where MLEC stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, MLEC finished 78.45% below its 150-day moving average ($7.10) and 79.24% below its 200-day moving average ($7.37). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is MLEC overbought or oversold?
At the October 20, 2026 close, MLEC's RSI(14) was 6.8, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
As with any equity investment, MLEC carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. No single metric tells the full story. Reviewing MLEC's risk profile alongside its fundamentals and technical indicators provides a more complete picture.